1. Home
  2. Companies
  3. CVB
  4. Material Events

Curvebeam AI (ASX:CVB) — Material Events

ASX:CVB · 15 articles in the last 12 months · 100% assessed

Click a band to jump to that tier

Major 1 article Significant 10 articles Notable 4 articles Not Assessed 0 articles
Major ≥90 Significant 75–89 Notable 50–74 Routine <50 Not assessed
Significant Score 75–89
10
CurveBeam AI Accelerates Growth with China JV and $6.5m Capital RaiseMedium
CurveBeam AI Q1 FY26: 33% PO growth, A$6.5m placement, China JV inked, FDA clearance targeted mid-2026
30 Oct 2025 ·Quarterly Company Call / Investor Presentation ·85
CurveBeam AI Raises A$6.5M, Advances Growth with Vendor Financing and China Deal TalksMedium
CurveBeam AI raises A$6.5M, secures €10M vendor financing, advances surgical robot validation, and pursues China partnership
29 Sept 2025 ·Capital Raising ·85
CurveBeam AI Reports FY2026 Revenue Drop Amid China Expansion and Capital RaiseMedium
CurveBeam AI reports FY2026 revenue decline, increased loss, advances China strategy, and plans capital raise
31 Aug 2026 ·Annual Report and Financial Statements ·85
CurveBeam AI Secures A$4 Million Strategic Investment to Fuel China ExpansionMedium
CurveBeam AI secures A$4 million strategic investment from Chinese orthopaedic device subsidiary
2 Feb 2026 ·Strategic Investment Announcement ·85
CurveBeam AI Raises A$6.5m to Accelerate HiRise™ CT Scanner ExpansionMedium
CurveBeam AI raises A$6.5m to expand HiRise™ CT scanner market with Stryker partnership and China deal in progress
29 Sept 2025 ·Investor Presentation and Capital Raising ·85
CurveBeam AI Secures $10M China Investment Backed by WEGO OrthopaedicsMedium
CurveBeam AI Secures China ODI Approval for A$10M Strategic Investment with WEGO Orthopaedics
7 Jan 2026 ·Strategic Investment Announcement ·85
CurveBeam AI Secures $4M Milestone, Advances FDA Filing and Device ValidationMedium
CurveBeam AI secures $4m China milestone, advances FDA filing, reports stable device orders and improved cash flow in Q2 FY26
29 Jan 2026 ·Appendix 4C & Quarterly Activity Report ·80
CurveBeam AI Accelerates Growth with China Deal and $6.5M Capital RaiseMedium
CurveBeam AI boosts device orders, secures A$6.5m placement, and finalizes China JV with A$10m investment
30 Oct 2025 ·Appendix 4C & Quarterly Activity Report ·80
CurveBeam AI Secures $4M Milestone, Advances FDA and China Regulatory PathwaysMedium
CurveBeam AI advances regulatory and commercial milestones with $4M milestone payment pending and FDA submission underway
29 Jan 2026 ·Quarterly Company Call Presentation ·75
CurveBeam AI Navigates Regulatory Delays Amid China JV and Clinical AdvancesMedium
CurveBeam AI reports steady device orders, regulatory delays, and strategic China partnership with A$4m investment
30 Apr 2026 ·Quarterly Activity Report and Appendix 4C ·75
Not Assessed Low Score, or missing data
0

No articles in this tier for the last 12 months.